| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |